Ziprasidone: zealous in the treatment of schizophrenia and schizoaffective disorder

被引：0

作者：

机构：

来源：

Drugs & Therapy Perspectives | 2003年 / 19卷 / 4期

关键词：

Schizophrenia; Haloperidol; Risperidone; Olanzapine; Ziprasidone;

D O I：

10.2165/00042310-200319040-00001

中图分类号：

学科分类号：

摘要：

引用

页码：1 / 4

页数：3

共 50 条

[21] Pharmacological treatment for schizoaffective disorder: A comparison with schizophrenia and bipolar disorder
Assion, H. -J.
Schweppe, A.
Reinbold, H.
Frommberger, U.
NERVENARZT, 2019, 90 : S1 - S8
[22] CHQ and CGAS in an open-label study of ziprasidone in pediatric patients with bipolar disorder, schizophrenia, or schizoaffective disorder
DelBello, Melissa
Stewart, Michelle
Versavel, Mark
Keller, David
Miceli, Jeffrey
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (06) : 662 - 662
[23] The efficacy and safety of ziprasidone 80 mg/day and 160 mg/day in schizophrenia and schizoaffective disorder
Daniel, D
Reeves, K
Harrigan, EP
SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 204 - 204
[24] Effects of oral ziprasidone and risperidone on cognitive functioning in patients with schizophrenia or schizoaffective disorder: Preliminary data
Mitchell, D
Hagger, C
Wise, AL
Schulz, SC
SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 116 - 116
[25] A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms
Kinon, BJ
Lipkovich, I
Edwards, SB
Adams, DH
Ascher-Svanum, H
Siris, SG
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (02) : 157 - 162
[26] BROMOCRIPTIN AND CABERGOLIN IN TREATMENT OF HYPERPROLACTINEMIA IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER
Gorobets, L.
Bulanov, V.
EUROPEAN PSYCHIATRY, 2011, 26
[27] Treatment response and gender in patients with schizophrenia and schizoaffective disorder
Howard, CH
Fiedosewicz, H
Patel, C
Klegon, DA
Bayog, R
Berman, I
SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 232 - 232
[28] Strategies for Improving Treatment Adherence in Schizophrenia and Schizoaffective Disorder
Goff, Donald C.
Hill, Michele
Freudenreich, Oliver
JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 : 20 - 26
[29] Psychopharmacological treatment of patients with schizoaffective disorder in comparison to schizophrenia and bipolar disorder
Assion, H. J.
Schweppe, A.
Skiba, M.
Juckel, G.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S321 - S322
[30] Anosognosia in schizophrenia and schizoaffective disorder
Amador, XF
Seckinger, RA
Kasapis, C
Limpert, C
Yale, SA
SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 10 - 10

← 1 2 3 4 5 →